We have updated the system! As some of you may be aware, one of the outcomes for Year 3 of the Community Pharmacy Contractual Framework is an expansion of the New Medicine Service (NMS).
To support our customers, RxWeb has been updated this week so that any newly prescribed medicines dispensed under one of the thirteen new categories and that are listed on the published NMS Drug Lists ( New Medicine Service (NMS) – Drug Lists | NHSBSA ), will be flagged to the user during the dispensing process, subject to you having NMS switched on in your system configuration.
NMS Expansion categories:
- Acute coronary syndrome (ACS);
- Atrial fibrillation (AF);
- Coronary heart disease;
- Epilepsy;
- Glaucoma;
- Gout;
- Heart failure;
- Hypercholesterolaemia ;
- Long term risks of venous thromboembolism/embolism;
- Osteoporosis;
- Parkinson’s Disease;
- Stroke / transient ischemic attack; and
- Urinary incontinence and retention.
Please note that the current NMS eligible conditions/medicines will also continue as before, but the antiplatelet/anticoagulant therapy group is now included in the above list by reference to the underlying condition/reason for prescribing.
Related news
Wrapping Up 2024 and Exciting Updates Ahead for 2025
As we approach the end of 2024, we want to take a moment to reflect on what we’ve achieved with our customers and share some exciting updates coming in January 2025.
Seamless Integration, Swift Setup: iPharmacy’s Positive Experience with RxWeb
Pharmacies depend on efficient, secure, and reliable PMR systems to support their essential role in patient health and community wellness. RxWeb delivers all of this and more.
Transforming Community Pharmacy: Thursfields Pharmacy’s Journey with RxWeb
Recently, our Sales Manager, Lindsay Power, and Product Analyst, Julian Horsley, had the privilege of visiting Thursfields Pharmacy.